ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

VTGN VistaGen Therapeutics Inc

4,74
-0,09 (-1,86%)
Após o horário de negociação
Última atualização: 17:30:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
VistaGen Therapeutics Inc VTGN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,09 -1,86% 4,74 17:30:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,85 4,72 4,93 4,74 4,83
mais cotações »

Notícias Recentes

Data Hora Fonte Título
25/04/202409:30BWVistagen Announces Positive Results from Phase 2A Pilot..
09/04/202409:30BWVistagen to Present at the 2024 Anxiety and Depression..
01/04/202409:30BWVistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol..
11/03/202409:30BWVistagen to Present at Stifel 2024 Virtual CNS Days
28/02/202410:30BWVistagen to Present at TD Cowen 44th Annual Health Care..
13/02/202418:20BWVistagen Reports Fiscal 2024 Third Quarter Financial Results..
06/02/202410:30BWVistagen to Report Fiscal Year 2024 Third Quarter Financial..
27/12/202310:30BWVistagen Receives Notice from European Patent Office of..
09/11/202318:30BWVistagen Provides Corporate Update and Reports Fiscal 2024..
08/11/202310:30BWVistagen to Present at Stifel 2023 Healthcare Conference
07/11/202310:30BWVistagen to Present Positive Fasedienol Phase 3 Data and..
06/11/202310:00BWVistagen To Report Second Quarter Financial Results and Host..
05/10/202309:30BWVistagen to Present at Jefferies Inaugural Biotech CNS/Neuro..
02/10/202308:30BWVistagen Announces Pricing of $100 Million Underwritten..
12/09/202309:30BWVistagen Announces Positive Results from Exploratory Phase..
05/09/202310:00BWVistagen and Fuji Enter Exclusive Negotiation Agreement for..
22/08/202309:30BWVistagen Appoints Cindy Anderson as Chief Financial Officer
10/08/202317:21BWSubsequent to the Release of Positive Phase 3 Trial Results,..
08/08/202317:30BWVistagen To Report First Quarter Financial Results and Host..
07/08/202309:30BWVistagen Announces Positive Top-Line Results from Phase 3..
17/07/202309:00BWVistagen Reports New Preclinical Data Supporting Itruvone..
13/07/202317:05BWVistagen Receives Notice of Allowance for AV-101 Canadian..
28/06/202317:25BWVistagen Provides Corporate Update and Reports Fiscal Year..
27/06/202317:30BWVistagen to Announce Fiscal Year 2023 Financial Results and..
23/06/202309:30BWVistagen Regains Full Compliance with Nasdaq Listing..
21/06/202309:30BWVistagen Announces Results of Successful U.S. Phase 1 Study..
16/06/202309:30BWVistagen to Participate in the Maxim Group Healthcare..
13/06/202309:00BWVistagen Announces European Patent Office Intention to Grant..
07/06/202310:00BWVistagen Announces Positive Results from Exploratory Phase..
06/06/202317:30BWVistagen to Present at Jefferies 2023 Global Healthcare..
06/06/202310:25BWVistagen Announces Stockholder-Approved Reverse Stock Split
01/06/202309:30BWVistagen Presents Fasedienol (PH94B) Safety and Exploratory..
30/05/202317:15BWVistagen to Present Fasedienol (PH94B) Safety and..
24/05/202309:30BWVistagen Awarded Mental Health America’s Platinum Bell Seal..

Seu Histórico Recente

Delayed Upgrade Clock